Web Results

Patent Docs: Court Report - Patentdocs.org

www.patentdocs.org/2013/03/court-2.html

Mar 31, 2013 ... Millennium Pharmaceuticals Inc. v. Fresenius Kabi USA LLC et al. 1:13-cv-00467 ; filed March 22, 2013 in the District Court of Delaware ...

Patent Docs: Court Report - Patentdocs.org

www.patentdocs.org/new_biotech_cases/page/3/

Nov 5, 2015 ... Boehringer Ingelheim Pharmaceuticals Inc. et al. v. HEC Pharm Co., Ltd. .... Mylan Pharma Acquisition Ltd. et al. v Fresenius Kabi USA, LLC 1:15-cv-06700; filed ..... Plaintiff: Millennium Pharmaceuticals Inc. • Defendants: Dr.

Millennium Pharmaceuticals Inc. v. Wockhardt Bio AG et al

search.rpxcorp.com/lit/dedce-58695-millennium-pharmaceuticals-v-wockhardt-bio

Millennium Pharmaceuticals Inc. v. Wockhardt Bio AG et al. 1:16-cv-00034; Filed: 01/22/2016; Closed: 03/22/2016; Latest Docket Entry: 03/24/2016; PACER.

Astellas Pharma Inc. et al v. Fresenius Kabi USA LLC - RPX Search

search.rpxcorp.com/lit/dedce-56530-astellas-pharma-v-fresenius-kabi

Astellas Pharma Inc. et al v. Fresenius Kabi USA LLC. 1:15-cv-00080; Filed: 01/ 23/2015; Closed: 04/01/2016; Latest Docket Entry: 04/01/2016; PACER.

Plaintiff(s) v. Defendant(s) :: Delaware District Court :: Federal Court ...

www.plainsite.org/dockets/sj98m4v1/delaware-district-court/plaintiffs-v-defendants/

Glory Boyz Entertainment, LLC, et al. ... COMPLAINT - Forest Laboratories, Inc., et al. v. .... 7.1 Statement, # 6 Millennium Pharmaceuticals, Inc. 7.1 Statement, # 7 Summons Forms - Unsigned Ben ...... COMPLAINT - Fresenius Kabi USA, LLC v.

Patent US8962572 - Bortezomib formulations - Google Patents

www.google.com/patents/US8962572

Feb 24, 2015 ... Original Assignee, Fresenius Kabi Usa, Llc .... 6,699,835 to Plamondon et al. ... VELCADE® for Injection (Millennium Pharmaceuticals, Inc.; .... with boric acid may be represented by one or more of structures V, VI and VII:.

Judge Leonard P. Stark - PlainSite

www.plainsite.org/judges/delaware-district-court/leonard-p-stark/

... Jr. v. First Niagara Financial Group, Inc. et al ... et al v. EMERALD NETWORKS, LLC et al .... v. Fresenius Kabi USA, LLC ... v. Millennium Pharmaceuticals Inc.

Updated Interim Efficacy Analysis and Long-term Safety of ... - NCBI

www.ncbi.nlm.nih.gov/pmc/articles/PMC4418928/

Mar 6, 2014 ... Abiraterone improved OS (median: 35.3 vs 30.1 mo; HR: 0.79 [95% CI, 0.66–0.95 ]; p = 0.0151) ..... Writing assistance was funded by Janssen Global Services, LLC . ... Teva Pharmaceuticals, Abbott Laboratories, Endo, Fresenius Kabi, Cougar Biotechnology, ... Heidenreich A, Bastian PJ, Bellmunt J, et al.

Maintenance of Efficacy and Continuing Safety of Golimumab for ...

www.nature.com/ctg/journal/v7/n4/full/ctg201624a.html

Apr 28, 2016 ... 11.10) and AEs leading to study agent discontinuation (12.72 vs. .... from Ferring Pharmaceuticals, Janssen Research & Development, LLC, Shering-Plough, AbbVie, ... LLC, Abbott/AbbVie, Shering-Plough, and Fresenius Kabi, having received research support ... Sandborn WJ, Feagan BG, Marano C et al.

More Info

Patent Docs: Court Report

www.patentdocs.org

3 days ago ... ... al. v. Glenmark Pharmaceuticals Inc., USA et al. ..... Boehringer Ingelheim Pharmaceuticals Inc. et al. v. ..... Fresenius Kabi USA, LLC et al. v.

here - Patent Docs

patentdocs.typepad.com

Oct 13, 2015 ... ROCHE PALO ALTO LLC,. Plaintiffs, v. FRESENIUS KABI USA, LLC,. Defendant. .... Inc. et al. v. Teva Pharmaceuticals USA Inc. et al., 1:14-cv-00778-. RGA (D. ... 13, 2013); Millennium Pharmaceuticals Inc. v. Fresenius Kabi.

Sanofi-Aventis US LLC et al v. Fresenius Kabi USA LLC - RPX Search

search.rpxcorp.com

Sanofi-Aventis US LLC et al v. Fresenius Kabi USA LLC. 1:14-cv-01496; Filed: 12 /18/2014; Closed: 03/24/ ... Biotech and Pharma. Court. District of Delaware.